Nature Reviews Cancer

Nature Reviews Cancer, published by Springer Nature, is a premier monthly journal dedicated to the field of oncology. With an impact factor of 60.700 in 2026 and consistently ranked in the top Q1 quartile of the Journal Citation Reports, it stands as one of the most authoritative and highly cited journals in cancer research. The journal’s scope encompasses the full spectrum of cancer biology, from fundamental molecular mechanisms and cellular pathways to translational advances, immunotherapy, tumor microenvironment dynamics, and emerging therapeutic strategies. It does not publish primary research articles; instead, its content is exclusively composed of expert-commissioned Review articles, Perspectives, and Opinion pieces that synthesize and critically evaluate the latest developments in the field. These articles are designed to provide comprehensive, accessible overviews of complex topics, making the journal an essential resource for a broad audience, including established researchers, clinical oncologists, graduate students, and biomedical professionals seeking to stay abreast of cutting-edge discoveries and paradigms. A defining feature of Nature Reviews Cancer is its rigorous peer-review process and high editorial standards, which ensure clarity, accuracy, and depth. While the journal is subscription-based, authors have the option to publish their articles open access. Its exceptional impact factor and Q1 ranking underscore its unparalleled influence and reputation as a definitive source of synthesized knowledge, shaping the direction of both basic and applied cancer research worldwide.